Search

The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.

Simulations of intrinsically disordered proteins (IDPs) pose numerous challenges to comparative analysis, prominently including highly dynamic conformational states and a lack of well-defined secondary structure. Machine learning (ML) algorithms are especially effective at discriminating among high-dimensional inputs whose differences are extremely subtle, making them well suited to the study of IDPs. In this work, we apply various ML techniques, including support vector machines (SVM) and clustering, as well as related methods such as principal component analysis (PCA) and protein structure network (PSN) analysis, to the problem of uncovering differences between configurational data from molecular dynamics simulations of two variants of the same IDP. We examine molecular dynamics (MD) trajectories of wild-type amyloid beta (Aβ1−40) and its “Arctic” variant (E22G), systems that play a central role in the etiology of Alzheimer's disease. Our analyses demonstrate ways in which ML and related approaches can be used to elucidate subtle differences between these proteins, including transient structure that is poorly captured by conventional metrics.